Alkermes plc
US ˙ NasdaqGS ˙ IE00B56GVS15

Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Richard F Pops. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att Richard F Pops har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:NBIX / Neurocrine Biosciences, Inc. Director 34 480
US:ALKS / Alkermes plc Director and CEO, Alkermes plc, Director 1 290 390
US:EPZM / Epizyme Inc Director 14 013
US:XLRN / Acceleron Pharma Inc Director 7 500
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Richard F Pops. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderköp ALKS / Alkermes plc - Analys av kortsiktig vinst

I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i ALKS / Alkermes plc. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
max
Pris vid
max
Max
vinst ($)
Maximal avkastning (%)
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

ALKS / Alkermes plc Insider Trades
Insiderförsäljning - Analys av kortsiktig förlust

I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i ALKS / Alkermes plc. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.

Handelsdatum Ticker Insider Rapporterade
aktier
Rapporterad
pris
Justerade
aktier
Justerat
pris
Kostnadsgrund Dagar till
min
Pris vid
min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2022-05-06 ALKS POPS RICHARD F 93 747 27,8549 93 747 27,8549 2 611 313 157 21.9400 −554 504 −21,23
2022-05-05 ALKS POPS RICHARD F 221 222 27,9504 221 222 27,9504 6 183 243
2022-05-05 ALKS POPS RICHARD F 32 288 28,5935 32 288 28,5935 923 227

Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.

ALKS / Alkermes plc Insider Trades
Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Richard F Pops som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris
Transaktionsvärde Återstående
värde
2025-05-22 2025-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 2 869 34 480 9,08
2025-02-07 2025-02-06 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −79 925 1 290 390 −5,83 31,39 −2 508 846 40 505 342
2025-02-07 2025-02-06 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 190 640 1 370 315 16,16
2024-05-21 2024-05-17 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −2 100 31 611 −6,23 141,84 −297 860 4 483 651
2024-05-21 2024-05-17 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 4 199 33 711 14,23
2024-03-15 2024-03-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −23 200 29 512 −44,01 140,33 −3 255 621 4 141 375
2024-03-15 2024-03-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 23 200 52 712 78,61 42,76 992 032 2 253 965
2024-03-12 2024-03-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −100 29 512 −0,34 140,00 −14 000 4 131 680
2024-03-12 2024-03-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 100 29 612 0,34 42,76 4 276 1 266 209
2024-03-12 2024-03-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −1 700 29 512 −5,45 140,05 −238 078 4 133 035
2024-03-12 2024-03-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 1 700 31 212 5,76 42,76 72 692 1 334 625
2024-02-22 2024-02-20 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −15 000 29 512 −33,70 132,47 −1 987 047 3 909 449
2024-02-22 2024-02-20 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15 000 44 512 50,83 12,98 194 700 577 766
2024-02-12 2024-02-08 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −91 757 1 179 675 −7,22 26,77 −2 456 335 31 579 900
2024-02-12 2024-02-08 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 218 551 1 271 432 20,76
2023-02-22 2023-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −14 386 1 052 881 −1,35 27,77 −399 499 29 238 505
2023-02-22 2023-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32 400 1 067 267 3,13
2023-02-22 2023-02-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −53 145 1 034 867 −4,88 28,07 −1 491 780 29 048 717
2023-02-22 2023-02-20 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 119 713 1 088 012 12,36
2023-01-05 2023-01-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −15 000 29 512 −33,70 119,20 −1 788 045 3 517 919
2023-01-05 2023-01-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15 000 44 512 50,83 12,71 190 650 565 748
2022-05-20 2022-05-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 9 724 9 724
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise −7 500 0 −100,00 6,66 −49 950
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise −7 500 0 −100,00 6,66 −49 950
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −7 500 29 512 −20,26 76,30 −572 252 2 251 772
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 7 500 37 012 25,41 6,66 49 950 246 500
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 7 500 37 012 25,41 6,66 49 950 246 500
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −7 500 29 512 −20,26 76,29 −572 211 2 251 612
2022-05-06 2022-05-06 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise −120 847 0 −100,00
2022-05-06 2022-05-06 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale −93 747 968 299 −8,83 27,85 −2 611 313 26 971 872
2022-05-06 2022-05-06 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 120 847 1 062 046 12,84 16,55 2 000 018 17 576 861
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise −329 153 120 847 −73,15
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale −32 288 941 199 −3,32 28,59 −923 227 26 912 174
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale −221 222 973 487 −18,52 27,95 −6 183 243 27 209 351
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 329 153 1 194 709 38,03 16,55 5 447 482 19 772 434
2022-02-23 2022-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −32 400 32 400 −50,00
2022-02-23 2022-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −14 386 865 556 −1,63 25,08 −360 801 21 708 144
2022-02-23 2022-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32 400 879 942 3,82
2022-02-23 2022-02-18 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 299 044 299 044
2022-02-17 2022-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −18 125 0 −100,00
2022-02-17 2022-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −8 038 847 542 −0,94 26,79 −215 338 22 705 650
2022-02-17 2022-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18 125 855 580 2,16
2021-09-16 2021-09-14 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −36 267 837 455 −4,15 30,60 −1 109 770 25 626 123
2021-09-16 2021-09-14 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 81 682 873 722 10,31
2021-05-20 2021-05-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 8 833 8 833
2021-05-19 2021-05-18 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −150 000 0 −100,00
2021-05-19 2021-05-18 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −150 000 792 040 −15,92 21,90 −3 285 405 17 347 815
2021-05-19 2021-05-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 150 000 942 040 18,94 18,10 2 715 750 17 055 634
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −150 000 150 000 −50,00
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −60 297 792 040 −7,07 22,30 −1 344 798 17 664 789
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −89 703 852 337 −9,52 21,95 −1 968 541 18 704 621
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 150 000 942 040 18,94 18,10 2 715 750 17 055 634
2021-05-07 2021-05-06 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −100 000 300 000 −25,00
2021-05-07 2021-05-06 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 792 040 −11,21 21,79 −2 179 410 17 261 799
2021-05-07 2021-05-06 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 892 040 12,63 18,10 1 810 500 16 150 384
2021-02-24 2021-02-22 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 342 187 342 187
2021-02-23 2021-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −32 400 64 800 −33,33
2021-02-23 2021-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −14 386 792 040 −1,78 19,58 −281 678 15 508 143
2021-02-23 2021-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32 400 806 426 4,19
2021-02-18 2021-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 750 0 −100,00
2021-02-18 2021-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 869 774 026 −0,50 19,97 −77 264 15 457 299
2021-02-18 2021-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 750 777 895 1,14
2021-02-18 2021-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −18 125 18 125 −50,00
2021-02-18 2021-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −8 074 769 145 −1,04 19,79 −159 784 15 221 380
2021-02-18 2021-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18 125 777 219 2,39
2020-06-02 2020-05-29 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 14 013 14 013
2020-05-21 2020-05-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 6 018 6 018
2020-05-14 2020-05-14 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −75 000 0 −100,00
2020-05-14 2020-05-14 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −75 000 759 094 −8,99 15,00 −1 125 232 11 388 763
2020-05-14 2020-05-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 75 000 834 094 9,88 11,74 880 500 9 792 264
2020-05-07 2020-05-07 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 75 000 −40,00
2020-05-07 2020-05-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 759 094 −6,18 14,63 −731 265 11 101 977
2020-05-07 2020-05-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 809 094 6,59 11,74 587 000 9 498 764
2020-04-03 2020-04-02 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 125 000 −28,57
2020-04-03 2020-04-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 759 094 −6,18 13,79 −689 500 10 467 906
2020-04-03 2020-04-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 809 094 6,59 11,74 587 000 9 498 764
2020-03-26 2020-03-26 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −75 000 175 000 −30,00
2020-03-26 2020-03-26 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −75 000 759 094 −8,99 14,36 −1 077 225 10 902 867
2020-03-26 2020-03-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 75 000 834 094 9,88 11,74 880 500 9 792 264
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −75 000 250 000 −23,08
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −15 986 759 094 −2,06 15,04 −240 393 11 415 028
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −48 668 775 080 −5,91 14,51 −706 168 11 246 333
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −10 346 823 748 −1,24 13,42 −138 867 11 056 593
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 75 000 834 094 9,88 11,74 880 500 9 792 264
2020-03-03 2020-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −17 500 0 −100,00
2020-03-03 2020-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −7 770 759 094 −1,01 20,84 −161 927 15 819 519
2020-03-03 2020-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17 500 766 864 2,34
2020-02-24 2020-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −32 400 97 200 −25,00
2020-02-24 2020-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −14 386 749 364 −1,88 20,24 −291 173 15 167 127
2020-02-24 2020-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32 400 763 750 4,43
2020-02-24 2020-02-20 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 358 466 358 466
2020-02-18 2020-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 750 8 750 −50,00
2020-02-18 2020-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 886 731 350 −0,53 17,77 −69 054 12 996 090
2020-02-18 2020-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 750 735 236 1,20
2020-02-18 2020-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −18 125 36 250 −33,33
2020-02-18 2020-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −8 072 726 486 −1,10 17,77 −143 439 12 909 656
2020-02-18 2020-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18 125 734 558 2,53
2019-11-15 2019-11-14 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −100 000 0 −100,00
2019-11-15 2019-11-14 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 716 433 −12,25 19,50 −1 950 000 13 970 444
2019-11-15 2019-11-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 816 433 13,96 9,21 921 000 7 519 348
2019-11-08 2019-11-08 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −30 205 100 000 −23,20
2019-11-08 2019-11-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −30 205 716 433 −4,05 19,73 −595 827 14 132 429
2019-11-08 2019-11-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30 205 746 638 4,22 9,21 278 188 6 876 536
2019-11-08 2019-11-07 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −69 795 130 205 −34,90
2019-11-08 2019-11-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −69 795 716 433 −8,88 19,81 −1 382 618 14 192 323
2019-11-08 2019-11-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 69 795 786 228 9,74 9,21 642 812 7 241 160
2019-09-23 2019-09-19 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −100 000 200 000 −33,33
2019-09-23 2019-09-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 716 433 −12,25 21,54 −2 153 550 15 428 743
2019-09-23 2019-09-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 816 433 13,96 9,21 921 000 7 519 348
2019-09-13 2019-09-12 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −100 000 300 000 −25,00
2019-09-13 2019-09-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 716 433 −12,25 22,68 −2 268 220 16 250 277
2019-09-13 2019-09-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 816 433 13,96 9,21 921 000 7 519 348
2019-09-06 2019-09-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −100 000 400 000 −20,00
2019-09-06 2019-09-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 716 433 −12,25 20,18 −2 017 830 14 456 400
2019-09-06 2019-09-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 816 433 13,96 9,21 921 000 7 519 348
2019-06-07 2019-05-31 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 17 633 17 633
2019-05-24 2019-05-23 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 0 −100,00
2019-05-24 2019-05-23 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 716 433 −6,52 24,22 −1 211 150 17 354 157
2019-05-24 2019-05-23 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 766 433 6,98 8,55 427 500 6 553 002
2019-05-24 2019-05-16 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −60 000 50 000 −54,55
2019-05-24 2019-05-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −60 000 716 433 −7,73 25,42 −1 525 278 18 212 658
2019-05-24 2019-05-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 60 000 776 433 8,37 8,55 513 000 6 638 502
2019-05-23 2019-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 10 000 10 000
2019-03-14 2019-03-13 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −15 829 110 000 −12,58
2019-03-14 2019-03-13 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −15 829 716 433 −2,16 33,51 −530 485 24 010 177
2019-03-14 2019-03-13 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 15 829 732 262 2,21 8,55 135 338 6 260 840
2019-03-14 2019-03-12 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −44 171 125 829 −25,98
2019-03-14 2019-03-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −44 171 716 433 −5,81 33,24 −1 468 447 23 817 529
2019-03-14 2019-03-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 44 171 760 604 6,17 8,55 377 662 6 503 164
2019-03-07 2019-03-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 170 000 −22,73
2019-03-07 2019-03-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 716 433 −6,52 33,63 −1 681 740 24 097 081
2019-03-07 2019-03-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 766 433 6,98 8,55 427 500 6 553 002
2019-03-04 2019-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −17 500 17 500 −50,00
2019-03-04 2019-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −7 770 716 433 −1,07 34,44 −267 599 24 673 953
2019-03-04 2019-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17 500 724 203 2,48
2019-02-27 2019-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −10 000 0 −100,00
2019-02-27 2019-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 887 706 703 −0,55 33,92 −131 847 23 971 366
2019-02-27 2019-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10 000 710 590 1,43
2019-02-25 2019-02-21 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 382 200 382 200
2019-02-25 2019-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 129 600 129 600
2019-02-25 2019-02-21 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 121 000 121 000
2019-02-19 2019-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 750 17 500 −33,33
2019-02-19 2019-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −2 573 700 590 −0,37 32,54 −83 725 22 797 199
2019-02-19 2019-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 750 703 163 1,26
2019-02-19 2019-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −18 125 54 375 −25,00
2019-02-19 2019-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −5 340 694 413 −0,76 32,54 −173 764 22 596 199
2019-02-19 2019-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18 125 699 753 2,66
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7 500 7 500
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1 250 32 500 4,00
2018-12-11 2018-12-07 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −12 224 681 628 −1,76 34,01 −415 738 23 182 168
2018-12-11 2018-12-07 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 27 500 693 852 4,13
2018-11-27 2018-11-26 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −4 124 29 512 −12,26 91,37 −376 790 2 696 367
2018-11-13 2018-11-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −4 123 33 636 −10,92 103,30 −425 893 3 474 491
2018-10-30 2018-10-29 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −5 500 37 759 −12,71 107,13 −589 237 4 045 273
2018-05-31 2018-05-18 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12 500 12 500
2018-05-25 2018-05-24 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 12 500 12 500
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −20 000 0 −100,00
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −3 682 666 352 −0,55 46,03 −169 495 30 674 382
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −16 318 670 034 −2,38 45,33 −739 669 30 371 569
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 20 000 686 352 3,00 12,29 245 800 8 435 266
2018-05-17 2018-05-15 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 20 000 −71,43
2018-05-17 2018-05-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 666 352 −6,98 46,38 −2 319 100 30 906 738
2018-05-17 2018-05-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 716 352 7,50 12,29 614 500 8 803 966
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 70 000 −41,67
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −7 360 666 352 −1,09 44,55 −327 863 29 683 716
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −42 640 673 712 −5,95 44,28 −1 887 912 29 829 003
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 716 352 7,50 12,29 614 500 8 803 966
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 120 000 −29,41
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −900 666 352 −0,13 44,66 −40 197 29 761 479
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −49 100 667 252 −6,85 44,01 −2 160 970 29 366 828
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 716 352 7,50 12,29 614 500 8 803 966
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise 15 000 0 −100,00 7,05 105 750
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes −1 253 43 259 −2,81 84,39 −105 741 3 650 627
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15 000 44 512 50,83 7,05 105 750 313 810
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −37 500 0 −100,00
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale −2 902 31 250 −8,50 42,32 −122 813 1 322 500
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale −34 598 34 152 −50,32 41,34 −1 430 281 1 411 844
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 37 500 68 750 120,00 5,08 190 500 349 250
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7 500 7 500
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1 250 31 250 4,17
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 000 0 −100,00
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −5 779 666 352 −0,86 60,05 −347 029 40 014 438
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 000 672 131 1,97
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −17 500 35 000 −33,33
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −7 779 659 131 −1,17 57,41 −446 592 37 840 711
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17 500 666 910 2,69
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −10 000 10 000 −50,00
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −4 445 649 410 −0,68 58,12 −258 343 37 743 709
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10 000 653 855 1,55
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 750 26 250 −25,00
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −2 581 643 855 −0,40 67,26 −173 598 43 305 687
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 750 646 436 1,37
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 295 000 295 000
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 72 500 72 500
2017-11-03 2017-11-02 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X −50 000 0 −100,00
2017-11-03 2017-11-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 637 686 −7,27 48,87 −2 443 410 31 162 567
2017-11-03 2017-11-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 687 686 7,84 14,13 706 500 9 717 003
2017-06-26 2017-06-22 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12 500 12 500
2017-06-08 2017-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15 000 15 000
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 750 0 −100,00
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −6 470 637 686 −1,00 57,70 −373 319 36 794 482
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 750 644 156 2,18
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X −6 269 0 −100,00
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −18 731 0 −100,00
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −25 000 630 406 −3,81 57,42 −1 435 535 36 198 795
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 6 269 655 406 0,97 15,95 99 991 10 453 726
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 18 731 649 137 2,97 15,95 298 759 10 353 735
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 18 731 −72,75
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −5 939 630 406 −0,93 59,06 −350 743 37 230 265
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −32 406 636 345 −4,85 58,37 −1 891 639 37 145 430
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −11 655 668 751 −1,71 57,23 −667 058 38 275 027
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 680 406 7,93 15,95 797 500 10 852 476
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −25 000 68 731 −26,67
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −7 841 630 406 −1,23 57,67 −452 156 36 352 740
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −17 159 638 247 −2,62 57,12 −980 088 36 455 392
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 25 000 655 406 3,97 15,95 398 750 10 453 726
2017-05-05 2017-05-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise −15 000 0 −100,00
2017-05-05 2017-05-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes −952 29 512 −3,12 53,37 −50 808 1 575 055
2017-05-05 2017-05-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15 000 30 454 97,06 3,40 51 000 103 544
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7 500 7 500
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1 250 30 000 4,35
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 000 13 000 −50,00
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −6 117 630 406 −0,96 60,97 −372 953 38 435 854
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 000 636 523 2,08
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −17 500 52 500 −25,00
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −8 234 623 523 −1,30 59,71 −491 652 37 230 558
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17 500 631 757 2,85
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −10 000 20 000 −33,33
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −4 705 614 257 −0,76 52,98 −249 271 32 543 336
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10 000 618 962 1,64
2017-02-21 2017-02-17 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 200 000 200 000
2017-02-21 2017-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 35 000 35 000
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −30 000 0 −100,00
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −2 050 608 962 −0,34 57,72 −118 320 35 147 642
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −27 950 611 012 −4,37 56,93 −1 591 149 34 783 936
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30 000 638 962 4,93 14,38 431 400 9 188 274
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −30 000 30 000 −50,00
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −6 885 608 962 −1,12 59,44 −409 218 36 194 326
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −23 115 615 847 −3,62 58,43 −1 350 718 35 986 835
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30 000 638 962 4,93 14,38 431 400 9 188 274
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −30 000 60 000 −33,33
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −2 060 608 962 −0,34 59,29 −122 133 36 104 200
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −27 940 611 022 −4,37 58,78 −1 642 391 35 917 584
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30 000 638 962 4,93 14,38 431 400 9 188 274
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −30 000 90 000 −25,00
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −8 946 608 962 −1,45 53,82 −481 466 32 773 787
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −21 054 617 908 −3,30 53,05 −1 116 997 32 782 429
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30 000 638 962 4,93 14,38 431 400 9 188 274
2016-10-07 2016-10-05 4 ALKS Alkermes plc.
Performance Restricted Stock Units
M - Exercise −20 000 0 −100,00
2016-10-07 2016-10-05 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −9 410 608 962 −1,52 46,43 −436 906 28 274 106
2016-10-07 2016-10-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 20 000 618 372 3,34
2016-06-01 2016-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 750 13 750 −50,00
2016-06-01 2016-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 750 598 372 2,35
2016-05-26 2016-05-25 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X −15 000 15 464 −49,24 46,72 −700 800 722 478
2016-05-24 2016-05-20 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15 000 15 000
2016-05-24 2015-05-28 4/A NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 25 000 25 000
2016-05-23 2016-05-19 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12 500 12 500
2016-05-23 2016-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 0 −100,00
2016-05-23 2016-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 584 622 1,41
2016-05-18 2016-05-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise −15 000 0 −100,00
2016-05-18 2016-05-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes −1 008 30 464 −3,20 45,64 −46 005 1 390 377
2016-05-18 2016-05-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15 000 31 472 91,06 3,07 46 050 96 619
2016-04-20 2016-04-19 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −18 750 0 −100,00
2016-04-20 2016-04-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −18 750 576 497 −3,15 40,15 −752 863 23 147 911
2016-04-20 2016-04-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 18 750 595 247 3,25 20,79 389 812 12 375 185
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −25 000 18 750 −57,14
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −1 700 576 497 −0,29 38,24 −65 008 22 045 245
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −23 300 578 197 −3,87 37,76 −879 831 21 833 297
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 25 000 601 497 4,34 20,79 519 750 12 505 123
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −25 000 43 750 −36,36
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −15 000 576 497 −2,54 32,05 −480 717 18 475 461
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −10 000 591 497 −1,66 31,36 −313 636 18 551 475
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 25 000 601 497 4,34 20,79 519 750 12 505 123
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −20 190 68 750 −22,70
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X −4 810 0 −100,00
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −25 000 576 497 −4,16 31,40 −784 910 18 099 930
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 20 190 601 497 3,47 20,79 419 750 12 505 123
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 4 810 581 307 0,83 20,79 100 000 12 085 373
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10 000 10 000
2016-03-04 2016-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 000 26 000 −33,33
2016-03-04 2016-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 000 576 497 2,31
2016-03-01 2016-02-29 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 70 000 70 000
2016-03-01 2016-02-29 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 300 000 300 000
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −10 000 30 000 −25,00
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10 000 563 497 1,81
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X −5 376 0 −100,00
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −32 124 0 −100,00
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −882 553 497 −0,16 73,52 −64 841 40 690 609
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −9 210 554 379 −1,63 72,51 −667 799 40 196 913
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −27 408 563 589 −4,64 71,87 −1 969 794 40 504 747
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 5 376 590 997 0,92 18,60 99 994 10 992 544
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 32 124 585 621 5,80 18,60 597 506 10 892 551
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 32 124 −60,88
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −2 200 553 497 −0,40 73,46 −161 602 40 657 454
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −24 052 555 697 −4,15 72,48 −1 743 171 40 274 196
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −23 748 579 749 −3,94 71,99 −1 709 571 41 734 971
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 603 497 9,03 18,60 930 000 11 225 044
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Performance Restricted Stock Units
A - Award 20 000 20 000
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −9 420 553 497 −1,67 59,77 −563 033 33 082 516
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 20 000 562 917 3,68
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 82 124 −37,84
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −27 579 542 917 −4,83 71,58 −1 974 072 38 861 347
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −22 421 570 496 −3,78 70,88 −1 589 189 40 436 471
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 592 917 9,21 18,60 930 000 11 028 256
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 132 124 −27,45
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −20 009 542 917 −3,55 68,12 −1 363 013 36 983 506
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −29 991 562 926 −5,06 67,20 −2 015 374 37 828 233
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 592 917 9,21 18,60 930 000 11 028 256
2015-07-10 2015-07-08 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 7 333 7 333
2015-06-01 2015-05-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 25 000 25 000
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 750 27 500 −33,33
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −6 477 542 917 −1,18 59,92 −388 102 32 531 587
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 750 549 394 2,57
2015-05-22 2015-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 8 125 −50,00
2015-05-22 2015-05-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 827 535 644 −0,71 61,80 −236 509 33 102 799
2015-05-22 2015-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 539 471 1,53
2015-05-22 2015-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 0 −100,00
2015-05-22 2015-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 827 531 346 −0,72 62,10 −237 657 32 996 587
2015-05-22 2015-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 535 173 1,54
2015-05-13 2015-05-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise −15 000 0 −100,00
2015-05-13 2015-05-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes −1 801 16 472 −9,86 39,63 −71 374 652 785
2015-05-13 2015-05-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15 000 18 273 458,30 4,76 71 400 86 979
2015-04-08 2015-01-08 4/A XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10 000 10 000
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 000 39 000 −25,00
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −6 123 526 940 −1,15 72,80 −445 754 38 361 232
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 000 533 063 2,50
2015-02-27 2015-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 40 000 40 000
2015-02-27 2015-02-26 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 200 000 200 000
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10 000 10 000
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 0 −100,00
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −4 621 520 063 −0,88 56,76 −262 292 29 519 192
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −45 379 524 684 −7,96 56,14 −2 547 759 29 457 858
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 50 000 −50,00
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −1 500 520 063 −0,29 56,56 −84 837 29 413 567
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −48 500 521 563 −8,51 55,86 −2 709 302 29 135 500
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-11-13 2014-11-13 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 100 000 −33,33
2014-11-13 2014-11-13 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 520 063 −8,77 52,88 −2 643 990 27 500 827
2014-11-13 2014-11-13 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-11-13 2014-11-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 150 000 −25,00
2014-11-13 2014-11-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 520 063 −8,77 52,86 −2 643 175 27 492 350
2014-11-13 2014-11-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 200 000 −20,00
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −31 800 520 063 −5,76 41,34 −1 314 488 21 497 376
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −18 200 551 863 −3,19 40,90 −744 424 22 572 521
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 250 000 −16,67
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −12 700 520 063 −2,38 41,50 −527 096 21 584 487
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −37 300 532 763 −6,54 40,91 −1 526 014 21 796 347
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-09-19 2014-09-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 300 000 −14,29
2014-09-19 2014-09-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 520 063 −8,77 44,89 −2 244 585 23 346 512
2014-09-19 2014-09-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 14,90 745 000 8 493 939
2014-07-25 2014-07-23 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 7 333 7 333
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 0 −100,00
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −1 400 520 063 −0,27 52,07 −72 904 27 082 073
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −48 600 521 463 −8,53 51,68 −2 511 463 26 947 226
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 12,30 615 000 7 011 775
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 50 000 −50,00
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −200 520 063 −0,04 50,70 −10 140 26 367 194
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −49 800 520 263 −8,74 49,87 −2 483 546 25 945 724
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 570 063 9,61 12,30 615 000 7 011 775
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −41 870 100 000 −29,51
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X −8 130 0 −100,00
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −1 300 520 063 −0,25 47,51 −61 765 24 709 025
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −48 700 521 363 −8,54 46,70 −2 274 246 24 347 183
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 41 870 570 063 7,93 12,30 515 001 7 011 775
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 8 130 528 193 1,56 12,30 99 999 6 496 774
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −13 750 41 250 −25,00
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −6 484 520 063 −1,23 45,74 −296 578 23 787 682
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13 750 526 547 2,68
2014-05-22 2014-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15 000 15 000
2014-05-22 2014-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 16 250 −33,33
2014-05-22 2014-05-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 831 512 797 −0,74 44,48 −170 403 22 809 211
2014-05-22 2014-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 516 628 1,60
2014-05-22 2014-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 8 125 −50,00
2014-05-22 2014-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 831 508 503 −0,75 43,98 −168 487 22 363 962
2014-05-22 2014-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 512 334 1,61
2014-05-20 2014-05-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 0 −100,00
2014-05-20 2014-05-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 831 504 209 −0,75 43,59 −166 993 21 978 470
2014-05-20 2014-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 508 040 1,63
2014-05-14 2014-05-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
M - Exercise −12 000 0 −100,00
2014-05-14 2014-05-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes −10 258 3 273 −75,81 14,47 −148 433 47 360
2014-05-14 2014-05-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 12 000 13 531 783,80 12,37 148 440 167 378
2014-03-05 2014-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 52 000 52 000
2014-03-05 2014-03-03 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 230 000 230 000
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 20 000 20 000
2013-11-19 2013-11-18 4 ALKS Alkermes plc.
Restricted Stock Award
M - Exercise −125 000 0 −100,00
2013-11-19 2013-11-18 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −59 001 499 915 −10,56 36,89 −2 176 547 18 441 864
2013-11-19 2013-11-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 125 000 558 916 28,81
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
28 750
2013-08-14 2013-08-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −34 125 0 −100,00
2013-08-14 2013-08-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −34 125 433 916 −7,29 33,26 −1 135 141 14 433 869
2013-08-14 2013-08-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 34 125 468 041 7,86 12,16 414 960 5 691 379
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −49 625 0 −100,00
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 34 125 −59,44
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −10 700 433 916 −2,41 35,41 −378 867 15 364 141
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −88 925 444 616 −16,67 34,85 −3 098 681 15 493 089
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 49 625 533 541 10,25 14,57 723 036 7 773 692
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 483 916 11,52 12,16 608 000 5 884 419
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 84 125 −37,28
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 84 125 −37,28
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 433 916 −10,33 28,19 −1 409 735 12 234 131
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 433 916 −10,33 28,19 −1 409 735 12 234 131
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 483 916 11,52 12,16 608 000 5 884 419
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 483 916 11,52 14,57 728 500 7 050 656
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 134 125 −27,16
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 134 125 −27,16
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 433 916 −10,33 29,84 −1 492 050 12 948 487
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 433 916 −10,33 29,84 −1 492 050 12 948 487
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 483 916 11,52 12,16 608 000 5 884 419
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 483 916 11,52 14,57 728 500 7 050 656
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Stock Option (right to buy)
A - Award 17 666 17 666
2013-05-30 3 EPZM Epizyme, Inc.
Common Stock
60 000
2013-05-29 2013-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 55 000 55 000
2013-05-29 2013-05-28 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 300 000 300 000
2013-05-23 2013-05-23 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15 000 15 000
2013-05-22 2013-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 24 375 −25,00
2013-05-22 2013-05-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 835 433 916 −0,88 31,98 −122 643 13 876 634
2013-05-22 2013-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 437 751 1,89
2013-05-21 2013-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 16 250 −33,33
2013-05-21 2013-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 835 429 626 −0,88 31,04 −119 038 13 335 591
2013-05-21 2013-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 433 461 1,91
2013-05-21 2013-05-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 8 125 −50,00
2013-05-21 2013-05-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 836 425 336 −0,89 31,69 −121 563 13 478 898
2013-05-21 2013-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 429 172 1,93
2013-04-01 2013-03-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
M - Exercise −12 000 0 −100,00
2013-04-01 2013-03-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes −10 469 1 531 −87,24 12,15 −127 198 18 602
2013-04-01 2013-03-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 12 000 12 000 10,60 127 200 127 200
2013-02-26 2013-02-25 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −16 250 0 −100,00
2013-02-26 2013-02-25 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −16 250 421 047 −3,72 20,72 −336 654 8 722 915
2013-02-26 2013-02-25 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 16 250 437 297 3,86 9,97 162 012 4 359 851
2013-02-20 2013-02-19 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 16 250 −75,47
2013-02-20 2013-02-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 421 047 −10,61 20,96 −1 048 155 8 826 450
2013-02-20 2013-02-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 471 047 11,88 9,97 498 500 4 696 339
2013-01-23 2013-01-22 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −50 000 66 250 −43,01
2013-01-23 2013-01-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 421 047 −10,61 22,30 −1 114 775 9 387 453
2013-01-23 2013-01-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50 000 471 047 11,88 9,97 498 500 4 696 339
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −39 970 116 250 −25,59
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X −10 030 0 −100,00
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −50 000 421 047 −10,61 21,91 −1 095 650 9 226 403
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 39 970 471 047 9,27 9,97 398 501 4 696 339
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 10 030 431 077 2,38 9,97 99 999 4 297 838
2012-11-19 2012-11-18 4 ALKS Alkermes plc.
Restricted Stock Award
M - Exercise −125 000 125 000 −50,00
2012-11-19 2012-11-18 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −52 126 421 047 −11,02 19,49 −1 015 936 8 206 206
2012-11-19 2012-11-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 125 000 473 173 35,90
2012-11-14 2012-11-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −12 100 0 −100,00
2012-11-14 2012-11-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −12 100 348 173 −3,36 20,25 −244 966 7 048 797
2012-11-14 2012-11-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 12 100 360 273 3,48 7,36 89 056 2 651 609
2012-10-19 2012-10-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −2 900 12 100 −19,33
2012-10-19 2012-10-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −2 900 348 173 −0,83 20,00 −58 000 6 963 460
2012-10-19 2012-10-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 2 900 351 073 0,83 7,36 21 344 2 583 897
2012-10-09 2012-10-09 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −41 900 15 000 −73,64
2012-10-09 2012-10-09 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −41 900 348 173 −10,74 20,31 −850 939 7 070 976
2012-10-09 2012-10-09 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 41 900 390 073 12,03 7,36 308 384 2 870 937
2012-10-09 2012-10-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −58 100 56 900 −50,52
2012-10-09 2012-10-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −58 100 348 173 −14,30 20,57 −1 195 384 7 163 520
2012-10-09 2012-10-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 58 100 406 273 16,69 7,36 427 616 2 990 169
2012-10-03 2012-10-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −100 000 115 000 −46,51
2012-10-03 2012-10-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 348 173 −22,31 20,52 −2 051 660 7 143 326
2012-10-03 2012-10-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 448 173 28,72 7,36 736 000 3 298 553
2012-09-26 2012-09-24 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −100 000 215 000 −31,75
2012-09-26 2012-09-24 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −100 000 348 173 −22,31 20,72 −2 072 500 7 215 885
2012-09-26 2012-09-24 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100 000 448 173 28,72 7,36 736 000 3 298 553
2012-07-09 2012-07-09 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −61 801 0 −100,00
2012-07-09 2012-07-09 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −61 801 348 173 −15,07 17,52 −1 082 871 6 100 652
2012-07-09 2012-07-09 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 61 801 409 974 17,75 4,77 294 791 1 955 576
2012-07-06 2012-07-05 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −7 900 61 801 −11,33
2012-07-06 2012-07-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −7 900 348 173 −2,22 18,01 −142 309 6 271 919
2012-07-06 2012-07-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 7 900 356 073 2,27 4,77 37 683 1 698 468
2012-07-06 2012-07-03 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −30 299 69 701 −30,30
2012-07-06 2012-07-03 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X −30 299 348 173 −8,01 18,00 −545 446 6 267 845
2012-07-06 2012-07-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30 299 378 472 8,70 4,77 144 526 1 805 311
2012-05-29 2012-05-27 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −1 981 348 173 −0,57 16,14 −31 973 5 619 512
2012-05-24 2012-05-23 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15 000 15 000
2012-05-22 2012-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 32 500 32 500
2012-05-22 2012-05-21 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 450 000 450 000
2012-05-21 2012-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 24 375 −25,00
2012-05-21 2012-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 389 350 154 −0,96 16,42 −55 647 5 749 529
2012-05-21 2012-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 353 543 2,35
2012-05-18 2012-05-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise −8 125 16 250 −33,33
2012-05-18 2012-05-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes −3 389 345 418 −0,97 16,71 −56 630 5 771 935
2012-05-18 2012-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8 125 348 807 2,38
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X −20 968 0 −100,00
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −4 032 100 000 −3,88
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X −35 000 315 000 −10,00
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
S - Sale X −20 968 340 682 −5,80 18,83 −394 895 6 416 132
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
M - Exercise X 20 968 361 650 6,15 4,77 100 017 1 725 070
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
S - Sale X −4 032 340 682 −1,17 18,83 −75 935 6 416 132
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
M - Exercise X 4 032 344 714 1,18 4,77 19 233 1 644 286
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
S - Sale X −35 000 340 682 −9,32 18,83 −659 162 6 416 132
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
M - Exercise X 35 000 375 682 10,27 7,36 257 600 2 765 020
2012-01-31 2012-01-27 4 ALKS Alkermes plc.
Restricted Stock Award
M - Exercise −25 000 0 −100,00
2012-01-31 2012-01-27 4 ALKS Alkermes plc.
Common Stock
F - Taxes −8 045 340 682 −2,31 19,10 −153 660 6 507 026
2012-01-31 2012-01-27 4 ALKS Alkermes plc.
Common Stock
M - Exercise 25 000 348 727 7,72
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)